Literature DB >> 2909417

Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis.

M P Greydanus1, M Camilleri.   

Abstract

Two hypotheses were tested: first, the postcibal motility disorders occur in both the antrum and small bowel of systemic sclerosis patients with gastrointestinal symptoms; second, that dysmotility may result from a neuropathic stage in this disease. Upper gut perfusion manometry (3 h fasting, 2 h fed) was performed and compared with data from similarly studied healthy laboratory controls (n = 15). Only 1 of 8 scleroderma patients had an interdigestive motor complex during the 3-h fasting period [0.1 +/- 0.1 (SEM) for systemic sclerosis vs. 1.4 +/- 0.16 (SEM) for controls, p less than 0.05]; 2 other patients had fasting duodenal incoordinated bursts of phasic pressure activity in the duodenum or proximal jejunum. Distal antral motility index [MI = In (sum of amplitude x number of contractions + 1)] was lower (12.4 +/- 0.5, p less than 0.01) than that in controls (14.4 +/- 0.14); both the amplitude and frequency of antral pressure activity were lower (p less than 0.05) in systemic sclerosis. The intestinal fed pattern was characterized by reduced amplitude and frequency of contractions in 6 patients; 2 patients had excessive phasic or tonic small bowel pressure activity, or both. Thus, antral hypomotility is present in most symptomatic scleroderma patients; proximal small bowel postcibal motility is characteristically reduced; a minority of such patients have incoordianted fasting or postcibal hypermotility suggestive of a neuropathy. Manometry identifies the type and region of dysmotility in systemic sclerosis; our results suggest that there are neuropathic and myopathic stages of the upper gut involvement in systemic sclerosis.

Entities:  

Mesh:

Year:  1989        PMID: 2909417     DOI: 10.1016/0016-5085(89)90770-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.

Authors:  Nicolas Richard; Marie Hudson; Mianbo Wang; Geneviève Gyger; Susanna Proudman; Wendy Stevens; Mandana Nikpour; Murray Baron
Journal:  Rheumatology (Oxford)       Date:  2019-04-01       Impact factor: 7.580

2.  [Acrocyanosis: crucial symptom in a case of chronic diarrhea and weight loss].

Authors:  N Hackelsberger; T Schmidt; A Stein; W Schepp
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

3.  Antroduodenal manometry.

Authors:  S F Phillips; M Camilleri
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

4.  Investigation of anal function in patients with systemic sclerosis.

Authors:  A L Herrick; J D Barlow; A Bowden; N Williams; A R Hobson; M Irving; M I Jayson
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

5.  Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients.

Authors:  T A McNearney; H S Sallam; S E Hunnicutt; D Doshi; D E Wollaston; M D Mayes; J D Z Chen
Journal:  Neurogastroenterol Motil       Date:  2009-06-30       Impact factor: 3.598

6.  Antroduodenal manometry. Usefulness and limitations as an outpatient study.

Authors:  E M Quigley; J P Donovan; M J Lane; T F Gallagher
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

7.  Ambulatory small intestinal manometry. Detailed comparison of duodenal and jejunal motor activity in healthy man.

Authors:  A Wilmer; A Andrioli; G Coremans; J Tack; J Janssens
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

Review 8.  An ANMS-NASPGHAN consensus document on esophageal and antroduodenal manometry in children.

Authors:  R Rosen; J M Garza; N Tipnis; S Nurko
Journal:  Neurogastroenterol Motil       Date:  2017-11-27       Impact factor: 3.598

Review 9.  What are the important subsets of gastroparesis?

Authors:  M Camilleri; M Grover; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

10.  Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.

Authors:  G N Verne; E Y Eaker; E Hardy; C A Sninsky
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.